바이오메디컬 검사 및 분석 서비스 시장 : 기술, 최종사용자, 검사 유형, 샘플 유형별 - 세계 예측(2025-2030년)

The Biomedical Testing & Analysis Services Market was valued at USD 3.17 billion in 2023, expected to reach USD 3.38 billion in 2024, and is projected to grow at a CAGR of 7.94%, to USD 5.42 billion by 2030.

The Biomedical Testing & Analysis Services market encompasses a broad range of diagnostic and analytical services aimed at analyzing biological samples for disease diagnosis, therapeutic monitoring, and advanced research purposes. It plays a critical role in healthcare by providing essential data that guides clinical decision-making and ensures the safety and efficacy of treatment regimens. Key applications include pathology, toxicology, genetic testing, and clinical trials, with end-users ranging from hospitals, research institutes, and pharmaceutical companies to biotechnology firms. The market's growth is primarily influenced by the rising prevalence of chronic diseases, technological advancements such as automation and artificial intelligence in diagnostics, and the increasing emphasis on personalized medicine. Furthermore, the COVID-19 pandemic has accelerated the demand for rapid and accurate testing solutions, providing lucrative opportunities for market expansion. Noteworthy opportunities lie in the development of portable diagnostic solutions, expansion into emerging markets, and collaboration with tech companies to innovate AI-driven analytical tools.

However, some limitations and challenges persist, such as stringent regulatory frameworks, high costs associated with advanced diagnostic technologies, and issues related to data privacy and security. Additionally, market growth could be hindered by a shortage of skilled professionals and the complexities of integrating new technologies within existing healthcare infrastructures. Innovating in areas like non-invasive testing methods, real-time data analytics, and biobanking could offer substantial business growth potential. Research into enhancing test speed and accuracy, while reducing costs, will be essential. Adapting to the evolving landscape of regulatory requirements and focusing on strategic partnerships can also drive market success. Considering the competitive nature of this market, companies should leverage advancements in digital technology to improve service delivery and maximize customer satisfaction. By anticipating market trends and addressing existing challenges proactively, businesses can stay ahead in this dynamic and rapidly evolving sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biomedical Testing & Analysis Services Market

The Biomedical Testing & Analysis Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing demand for early disease detection and personalized medical treatment driving the biomedical testing market
  • Advancements in technology and automation enhancing the accuracy and efficiency of biomedical testing services
  • Rising prevalence of chronic diseases and aging population contributing to the growth of biomedical testing services
  • Growing adoption of genomics and proteomics studies in drug development and disease treatment boosting the market
• Market Restraints
  • Difficulties in ensuring stringent regulatory requirements and compliance standards for biomedical testing and analysis services
  • Intense competition from in-house testing capabilities and advanced automated systems in biomedical research facilities
• Market Opportunities
  • Collaborative partnerships between biotech firms and diagnostic labs accelerating innovation
  • Increased focus on non-invasive testing methods promoting more frequent and accessible healthcare screenings
  • Regulatory landscape and funding opportunities supporting advances in biomedical testing and analysis
• Market Challenges
  • Data privacy and security concerns associated with biomedical testing & analysis services
  • Lack of skilled professionals including lab technicians, bioinformatics experts, and clinical researcher

Porter's Five Forces: A Strategic Tool for Navigating the Biomedical Testing & Analysis Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biomedical Testing & Analysis Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biomedical Testing & Analysis Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biomedical Testing & Analysis Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biomedical Testing & Analysis Services Market

A detailed market share analysis in the Biomedical Testing & Analysis Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biomedical Testing & Analysis Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biomedical Testing & Analysis Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biomedical Testing & Analysis Services Market

A strategic analysis of the Biomedical Testing & Analysis Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biomedical Testing & Analysis Services Market, highlighting leading vendors and their innovative profiles. These include BioIVT, BioReliance Corporation, Charles River Laboratories International, Inc., Covance Inc., Envigo, Eurofins Scientific, Frontage Laboratories, Inc., ICON Central Laboratories, ICON plc, Inotiv, Inc., IQVIA Holdings Inc., Laboratory Corporation of America Holdings, Medpace Holdings, Inc., Parexel International Corporation, Pharmaceutical Product Development, LLC, PPD, Inc., PRA Health Sciences, Inc., SGS SA, Syneos Health, and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the Biomedical Testing & Analysis Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technology, market is studied across Cell-Based Tests, Clinical Chemistry, Hematology, Immunoassays, Mass Spectrometry, Microbiological Testing, and Molecular Diagnostics. The Cell-Based Tests is further studied across Cell Viability Assays, High Content Screening, and Live Cell Imaging. The Immunoassays is further studied across ELISA, Radioimmunoassay, and Western Blot. The Mass Spectrometry is further studied across Metabolomics and Proteomics. The Molecular Diagnostics is further studied across DNA Sequencing, Isothermal Nucleic Acid Amplification, Microarray, and PCR.
• Based on End Users, market is studied across Biotechnology & Pharmaceutical Companies, Diagnostic Laboratories, Hospitals & Clinics, and Research Institutions & Academic Centers.
• Based on Test Type, market is studied across Diagnostic, Preliminary Testing, Prognostic, Screening, and Therapeutic Monitoring.
• Based on Sample Type, market is studied across Blood, Cerebrospinal Fluid, Saliva, Stool, Tissue Biopsy, and Urine.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing demand for early disease detection and personalized medical treatment driving the biomedical testing market
    • 5.1.1.2. Advancements in technology and automation enhancing the accuracy and efficiency of biomedical testing services
    • 5.1.1.3. Rising prevalence of chronic diseases and aging population contributing to the growth of biomedical testing services
    • 5.1.1.4. Growing adoption of genomics and proteomics studies in drug development and disease treatment boosting the market
  • 5.1.2. Restraints
    • 5.1.2.1. Difficulties in ensuring stringent regulatory requirements and compliance standards for biomedical testing and analysis services
    • 5.1.2.2. Intense competition from in-house testing capabilities and advanced automated systems in biomedical research facilities
  • 5.1.3. Opportunities
    • 5.1.3.1. Collaborative partnerships between biotech firms and diagnostic labs accelerating innovation
    • 5.1.3.2. Increased focus on non-invasive testing methods promoting more frequent and accessible healthcare screenings
    • 5.1.3.3. Regulatory landscape and funding opportunities supporting advances in biomedical testing and analysis
  • 5.1.4. Challenges
    • 5.1.4.1. Data privacy and security concerns associated with biomedical testing & analysis services
    • 5.1.4.2. Lack of skilled professionals including lab technicians, bioinformatics experts, and clinical researcher
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Biomedical Testing & Analysis Services Market, by Technology

• 6.1. Introduction
• 6.2. Cell-Based Tests
  • 6.2.1. Cell Viability Assays
  • 6.2.2. High Content Screening
  • 6.2.3. Live Cell Imaging
• 6.3. Clinical Chemistry
• 6.4. Hematology
• 6.5. Immunoassays
  • 6.5.1. ELISA
  • 6.5.2. Radioimmunoassay
  • 6.5.3. Western Blot
• 6.6. Mass Spectrometry
  • 6.6.1. Metabolomics
  • 6.6.2. Proteomics
• 6.7. Microbiological Testing
• 6.8. Molecular Diagnostics
  • 6.8.1. DNA Sequencing
  • 6.8.2. Isothermal Nucleic Acid Amplification
  • 6.8.3. Microarray
  • 6.8.4. PCR

7. Biomedical Testing & Analysis Services Market, by End Users

• 7.1. Introduction
• 7.2. Biotechnology & Pharmaceutical Companies
• 7.3. Diagnostic Laboratories
• 7.4. Hospitals & Clinics
• 7.5. Research Institutions & Academic Centers

8. Biomedical Testing & Analysis Services Market, by Test Type

• 8.1. Introduction
• 8.2. Diagnostic
• 8.3. Preliminary Testing
• 8.4. Prognostic
• 8.5. Screening
• 8.6. Therapeutic Monitoring

9. Biomedical Testing & Analysis Services Market, by Sample Type

• 9.1. Introduction
• 9.2. Blood
• 9.3. Cerebrospinal Fluid
• 9.4. Saliva
• 9.5. Stool
• 9.6. Tissue Biopsy
• 9.7. Urine

10. Americas Biomedical Testing & Analysis Services Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Biomedical Testing & Analysis Services Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Biomedical Testing & Analysis Services Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. BioIVT
• 2. BioReliance Corporation
• 3. Charles River Laboratories International, Inc.
• 4. Covance Inc.
• 5. Envigo
• 6. Eurofins Scientific
• 7. Frontage Laboratories, Inc.
• 8. ICON Central Laboratories
• 9. ICON plc
• 10. Inotiv, Inc.
• 11. IQVIA Holdings Inc.
• 12. Laboratory Corporation of America Holdings
• 13. Medpace Holdings, Inc.
• 14. Parexel International Corporation
• 15. Pharmaceutical Product Development, LLC
• 16. PPD, Inc.
• 17. PRA Health Sciences, Inc.
• 18. SGS SA
• 19. Syneos Health
• 20. WuXi AppTec